Meeting News Coverage

TOTAL follow-up results reject manual thrombectomy as STEMI treatment strategy

October 15, 2015
SAN FRANCISCO — One-year follow-up data from the TOTAL trial presented at the annual TCT Scientific Symposium showed routine thrombus…
Meeting News CoveragePerspective

LEADERS FREE: Polymer-free drug-coated stent superior to BMS in patients with high bleeding risk

October 15, 2015
SAN FRANCISCO — A polymer-free biolimus-coated stent demonstrated better safety and efficacy than a bare-metal stent when used with a 1-month…
Meeting News Coverage

RIVER-PCI: Ranolazine fails to benefit patients with incomplete revascularization after PCI

October 15, 2015
SAN FRANCISCO — Treatment with ranolazine did not lower rates of ischemia-driven revascularization or hospitalization without revascularization…
Meeting News Coverage

Thrombus aspiration before PCI fails to reduce microvascular obstruction

October 14, 2015
SAN FRANCISCO — In patients with STEMI presenting for care late after the onset of symptoms, routine thrombus aspiration before PCI did not…
Meeting News Coverage

Paradigm to treat superficial femoral artery, popliteal disease with high calcification remains unclear

October 14, 2015
SAN FRANCISCO — In a session focused on lower-extremity intervention in superficial femoral artery and popliteal disease, one presenter…
Meeting News Coverage

ABSORB China: BVS achieves noninferiority vs. cobalt-chromium everolimus-eluting stent

October 14, 2015
SAN FRANCISCO — In a multicenter trial to enable approval of the Absorb bioresorbable vascular scaffold in China, the device was noninferior to…
Meeting News Coverage

PLATFORM: CTA, FFR strategy improves costs, quality of life

October 13, 2015
SAN FRANCISCO — Using CT to estimate fractional flow reserve in evaluating patients who are stable but show signs of CAD could improve resource…
Meeting News Coverage

Polymer-free stent demonstrates noninferiority for in-stent late lumen loss

October 13, 2015
SAN FRANCISCO — A novel drug-coated stent that is both polymer- and carrier-free was noninferior vs. first-generation paclitaxel-eluting stents…
Meeting News Coverage

Presentation reviews trial design, potential implications of LIBERTY-360, ENDOMAX

October 13, 2015
SAN FRANCISCO — The LIBERTY-360 and ENDOMAX trials have the potential to provide novel, much-needed data on the use of available endovascular…
Meeting News CoveragePerspective

ABSORB III: Bioresorbable scaffold noninferior to cobalt-chromium stent

October 12, 2015
SAN FRANCISCO — An everolimus-eluting bioresorbable vascular scaffold was noninferior to a cobalt-chromium everolimus-eluting stent for target…